Nausea and Upset Stomach: Some individuals may experience nausea, upset stomach, or gastrointestinal discomfort after receiving MIC+B12 injections
Therefore, after successful phase III studies, 3 mg liraglutide was approved for obesity therapy [38]
Other hepatokines also contribute to the metabolic dysfunction seen in MASLD: Angiopoietin-like protein 3 inhibits lipoprotein lipase activity, promoting dyslipidemia and insulin resistance, while fibroblast growth factor 21, though elevated in MASLD, shows reduced efficacy due to hepatic insulin resistance
Unexpected Pregnancies on GLP-1s: Whats Really Happening
Peptides are increasingly used in performance and recovery settings, particularly for tissue repair and inflammation control
Body odour, flatulence, increased appetite or rash may occur